Cargando…
Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells
The ability to engineer primary human B cells to differentiate into long-lived plasma cells and secrete a de novo protein may allow the creation of novel plasma cell therapies for protein deficiency diseases and other clinical applications. We initially developed methods for efficient genome editing...
Autores principales: | Hung, King L., Meitlis, Iana, Hale, Malika, Chen, Chun-Yu, Singh, Swati, Jackson, Shaun W., Miao, Carol H., Khan, Iram F., Rawlings, David J., James, Richard G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835153/ https://www.ncbi.nlm.nih.gov/pubmed/29273498 http://dx.doi.org/10.1016/j.ymthe.2017.11.012 |
Ejemplares similares
-
Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells
por: Hale, Malika, et al.
Publicado: (2017) -
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
por: Cheng, Rene Yu-Hong, et al.
Publicado: (2022) -
Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing
por: Hill, Tyler F., et al.
Publicado: (2023) -
In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods
por: Pattabhi, Sowmya, et al.
Publicado: (2019) -
The new editor—targeted genome engineering in the absence of homology-directed repair
por: Kueh, AJ, et al.
Publicado: (2016)